Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Cytokines

Recombinant Human EPO Protein, C-His

Catalog #:   EHB95701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: P01588
Protein length: Ala28-Arg193
Overview

Catalog No.

EHB95701

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Ala28-Arg193

Predicted molecular weight

22.28 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P01588

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.

Reconstitution

Reconstitute in sterile water for a stock solution.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

EPO, Erythropoietin, Epoetin

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human EPO
  • Bioactivity
    Detects Human EPO (Iv0055) in indirect ELISAs.
References

Context-Dependent Variability Of HIF Heterodimers Influences Interactions With Macromolecular And Small Molecule Partners., PMID:40502054

Comparative analysis of respiratory metabolism, blood physiology, antioxidant capacity, and hypoxia-related gene expression in Snowy White chickens raised at high and low altitudes., PMID:40483906

An immune-related signature based on molecular subtypes for predicting the prognosis and immunotherapy efficacy of hepatocellular carcinoma., PMID:40458412

Correlation between changes in haemorheology and the HIF-1/EPO pathway in children with Mycoplasma pneumoniae pneumonia., PMID:40434092

Rapid Reduction of Pro-Inflammatory Cytokines with an Oral Topical Composition Comprising Olive Oil, Trimethylglycine and Xylitol: A Randomized Double-Blind Controlled Trial., PMID:40430061

Proteomic analysis reveals proteins and pathways associated with the effects of Hippophae rhamnoides L. total flavonoids on ameliorating excessive erythropoiesis in high-altitude polycythemia mice., PMID:40403894

Two Birds with One Stone: Empowering Probiotic with Nanoenzyme for the Treatment of Inflammatory and Anemia through Oral Administration., PMID:40395049

Detection of erythropoietin in blood plasma through an SPRi-based biosensor., PMID:40393237

Crosstalk between kidney and bones: New perspective for modulating osteoporosis., PMID:40389172

Limited Utility of Serum Hepcidin as a Marker for Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients: An Analysis From the INFINITY Cohort., PMID:40371877

Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients., PMID:40370459

Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial., PMID:40369895

Evidence of a hormetic-like cytoprotective effect by erythropoietin in the SH-SY5Y cell model of oxygen-glucose deprivation., PMID:40368234

Effect of histidine and carnosine on haemoglobin recovery in anaemia induced-kidney damage and iron-loading mouse models., PMID:40355605

Therapeutic Hypothermia and Recombinant Erythropoietin Mitigate Brain Microvascular Endothelial Cell Dysfunction via Modulating the Pentose Phosphate Pathway., PMID:40343581

Mechanisms of Erythropoietin-Mediated Protection Against Retinal Ganglion Cell Apoptosis., PMID:40341414

Regulation of Erythropoietin Activity in Clear Renal Cell Carcinoma., PMID:40332447

Elucidating the Pivotal Neuroprotective Mechanisms and Therapeutic Variants of Erythropoietin in Neonatal Brain Injury., PMID:40325536

Intramuscular delivery of recombinant AAV expressing EpoR76E improves memory and is neuroprotective in 5xFAD transgenics., PMID:40321747

Factors associated with high hidden blood loss in patients undergoing primary total knee arthroplasty for osteoarthritis: a cross-sectional retrospective study of 1444 patients., PMID:40319268

Xin Sheng Hua Granule ameliorate chemotherapy-induced blood deficiency syndrome through ihibiting JAK1/STAT1 pathway activation., PMID:40316148

Ketone ester ingestion impairs exercise performance without impacting cognitive function or circulating EPO during acute hypoxic exposure., PMID:40315254

Identification of Hepatic-like EPO as a Cause of Polycythemia., PMID:40305710

Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study., PMID:40293460

Signaling mechanisms and cis -regulatory control of Samd14 in erythroid regeneration., PMID:40293138

(Pro)renin, Erythropoietin, Vitamin D and Urodilatin Release From Human Donor Kidneys During Normothermic Machine Perfusion: Predictors of Early Post-Transplant Outcome?, PMID:40278798

Epo-calypse now., PMID:40273262

Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity., PMID:40273234

Effects of remote ischemic preconditioning and/or erythropoietin on lung injury induced by skeletal ischemia reperfusion: role of the NLRP3 inflammasome., PMID:40272513

EPO Enhances Adaptation to Hypoxic Environment in the Freshwater Teleost (Micropterus salmoides) through the PI3K/AKT Pathway., PMID:40239033

Comparison of tendon healing using local platelet-rich plasma, erythropoietin, and erythropoietin-bevacizumab in a rat Achilles tenotomy model., PMID:40235417

Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector., PMID:40221815

ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury., PMID:40216181

The gut microbiota in mice with erythropoietin-induced abdominal aortic aneurysm., PMID:40212374

Noncoding RNA, ncRNA-a3, Epigenetically Regulates TAL1 Transcriptional Program During Erythropoiesis., PMID:40211453

Neuroprotective effects of arctigenin on cerebral ischemia-reperfusion injury in rats via the EPO/EPOR-JAK2-STAT5 signaling pathway., PMID:40206088

Immunosuppression of spleen in mice treated with erythropoietin: transcriptomic and immunological analysis., PMID:40191193

Baicalin-Geniposide combination modulates microglia polarization against chronic cerebral ischemia and concomitant kidney injury via the HIF-1α/EPO/NF-κB pathway., PMID:40174480

An updated patent review of EZH2 inhibitors (2024-present)., PMID:40116819

Erythropoietin in ICU patients receiving early red blood cell transfusions: A retrospective study of the impact on transfusion requirements., PMID:40112672

Catching cancer signals in the blood: Innovative pathways for early esophageal cancer diagnosis., PMID:40093671

Hypoxemia exerts detrimental effects on the choroid plexuses and cerebrospinal fluid system in rats., PMID:40075475

Primary hyperparathyroidism induces erythropoietin resistance through fibroblast growth factor 23., PMID:40067841

Clonal hematopoiesis landscape in frequent blood donors., PMID:40067117

PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy., PMID:40063241

Therapeutic strategies that modulate the acute phase of secondary spinal cord injury scarring and inflammation and improve injury outcomes., PMID:40042224

Learning Enabled Control for Optimal EPO Dosage in Virtual CKD Patients: Case of Bleeding and Missing Dosage., PMID:40039101

Interplay between iron metabolism, inflammation, and EPO-ERFE-hepcidin axis in RDEB-associated chronic anemia., PMID:40036737

Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome., PMID:40035626

[Temporal development of hypoxia markers in brachycephalic and -mesocephalic dogs after short physical exercise]., PMID:40033858

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human EPO Protein, C-His [EHB95701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only